Dr. Andras Heczey is a physician-scientist and full-time faculty in the Department of Pediatrics of Baylor College of Medicine, Section of Pediatric Hematology and Oncology. He is a member of the multidisciplinary solid tumor team and the Center for Cell and Gene Therapy (CAGT).
His research focuses on developing novel treatments for children with solid tumors by redirecting the immune system to attack cancer cells.
Dr. Heczey has studied and published the first adoptive immunotherapy approach utilizing Natural Killer T cells genetically modified to attack neuroblastoma, he is working on moving this approach from bench-to-bedside in a form of a Phase 1/2a clinical trial.
As the Director of the Liver Tumor Program of Texas Children's Hospital, Dr. Heczey has developed a strategy to target hepatoblastoma and hepatocellular carcinoma with genetically engineered T lymphocytes and he is currently evaluating this strategy in early Phase clinical trials in children and adults.
Dr. Heczey is a member of the Liver Tumor Program, the Neuroblastoma Program, the Solid Tumor Team and the Center for Advanced Innate Cell Therapy.